Anticoagulation Choice. Mayo Clin Proc. 2019 Apr;94(4):686-696. \[[PMC free article: PMC6450705](/pmc/articles/PMC6450705/)\] \[[PubMed: 30642640](https://pubmed.ncbi.nlm.nih.gov/30642640)\] 9. Giustozzi M, Agnelli G, Quattrocchi S, Acciarresi M, Alberti A, Caso V, Vedovati MC, Venti M, Paciaroni M. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation. Cerebrovasc Dis Extra. 2020;10(2):44-49. \[[PMC free article: PMC7250375](/pmc/articles/PMC7250375/)\] \[[PubMed: 32375143](https://pubmed.ncbi.nlm.nih.gov/32375143)\] 10. Pachón V, Trujillo-Santos J, Domènech P, Gallardo E, Font C, González-Porras JR, Pérez-Segura P, Maestre A, Mateo J, Muñoz A, Peris ML, Lecumberri R. Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus. TH Open. 2018 Oct;2(4):e373-e386. \[[PMC free article: PMC6524906](/pmc/articles/PMC6524906/)\] \[[PubMed: 31249964](https://pubmed.ncbi.nlm.nih.gov/31249964)\] 11. Mulder FI, Di Nisio M, Ay C, Carrier M, Bosch FTM, Segers A, Kraaijpoel N, Grosso MA, Zhang G, Verhamme P, Wang TF, Weitz JI, Middeldorp S, Raskob G, Beenen LFM, Büller HR, van Es N. Clinical implications of incidental venous thromboembolism in cancer patients. Eur Respir J. 2020 Feb;55(2) \[[PubMed: 31727694](https://pubmed.ncbi.nlm.nih.gov/31727694)\] 12. Maraveyas A, Muazzam I, Noble S, Bozas G. Advances in managing and preventing thromboembolic disease in cancer patients. Curr Opin Support Palliat Care. 2017 Dec;11(4):347-354. \[[PubMed: 29068809](https://pubmed.ncbi.nlm.nih.gov/29068809)\] 13. Leow AS, Sia CH, Tan BY, Loh JP. A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus. J Thromb Thrombolysis. 2018 Jul;46(1):68-73. \[[PubMed: 29616407](https://pubmed.ncbi.nlm.nih.gov/29616407)\] 14. Paciaroni M, Agnelli G, Caso V, Venti M, Milia P, Silvestrelli G, Parnetti L, Biagini S. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost. 2005 Jun;3(6):1218-23. \[[PubMed: 15892862](https://pubmed.ncbi.nlm.nih.gov/15892862)\] 15. Singh M, Sporn ZA, Schaff HV, Pellikka PA. ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison. J Am Coll Cardiol. 2019 Apr 09;73(13):1707-1718. \[[PubMed: 30947924](https://pubmed.ncbi.nlm.nih.gov/30947924)\] 16. Mejilla A, Guirguis M, Koshman S, Bungard TJ. Venous Thromboembolism Prophylaxis on General Internal Medicine Units: Are Patients Well Served by Current Practice? Can J Hosp Pharm. 2017 May-Jun;70(3):200-206. \[[PMC free article: PMC5491195](/pmc/articles/PMC5491195/)\] \[[PubMed: 28680173](https://pubmed.ncbi.nlm.nih.gov/28680173)\] 17. Donnellan E, Khorana AA. Cancer and Venous Thromboembolic Disease: A Review. Oncologist. 2017 Feb;22(2):199-207. \[[PMC free article: PMC5330704](/pmc/articles/PMC5330704/)\] \[[PubMed: 28174293](https://pubmed.ncbi.nlm.nih.gov/28174293)\] 18. Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e495S-e530S. \[[PMC free article: PMC3278058](/pmc/articles/PMC3278058/)\] \[[PubMed: 22315270](https://pubmed.ncbi.nlm.nih.gov/22315270)\] 19. Toyoda K. Antithrombotic